The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT ID: NCT06470919
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3522 participants
INTERVENTIONAL
2024-11-06
2025-10-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271)
NCT03252288
Healthy, Immunized Communities Study
NCT03854734
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
NCT01830257
Missed Opportunities for Vaccine Equity
NCT04834960
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Next Generation digital vaccine card with SMS reminders for upcoming vaccination(s)
SMS reminders for upcoming vaccination(s)
All parents/caregivers of children in participating villages will receive access to a digital vaccine card. This will be used for record-keeping application (digital vaccine registry). Selected parents/caregivers of children will receive SMS messages and reminders related to vaccination.
Pre-intervention cohort
This group will be compared to the post-intervention group to assess the digital vaccine card.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMS reminders for upcoming vaccination(s)
All parents/caregivers of children in participating villages will receive access to a digital vaccine card. This will be used for record-keeping application (digital vaccine registry). Selected parents/caregivers of children will receive SMS messages and reminders related to vaccination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
African Population and Health Research Center
OTHER
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emily Treleaven
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Treleaven, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Gershim Asiki, MBChB, MSc, PhD
Role: PRINCIPAL_INVESTIGATOR
African Population and Health Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
African Population and Health Reseach Center
Nairobi, Kenya, Kenya
Uganda Christian University
Kasese, Uganda, Uganda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00237101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.